Securities and Exchange Board of India (Sebi) on Friday relaxed rules governing financial disincentives imposed by the regulator on Market Infrastructure Institutions (MIIs) and individuals for omissions and commissions leading to technical glitches.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale